Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Enterprise Value: 2022-2023

Historic Enterprise Value for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $152.0 million.

  • Therapeutics' Enterprise Value rose 302.16% to $152.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $152.0 million, marking a year-over-year increase of 114.78%. This contributed to the annual value of $794.0 million for FY2024, which is 422.51% up from last year.
  • As of Q4 2023, Therapeutics' Enterprise Value stood at $152.0 million, which was up 268.47% from -$90.2 million recorded in Q3 2023.
  • Over the past 5 years, Therapeutics' Enterprise Value peaked at $152.0 million during Q4 2023, and registered a low of -$162.9 million during Q2 2022.
  • For the 2-year period, Therapeutics' Enterprise Value averaged around -$60.3 million, with its median value being -$82.7 million (2022).
  • Over the last 5 years, Therapeutics' Enterprise Value had its largest YoY gain of 302.16% in 2023, and its largest YoY loss of 37.90% in 2023.
  • Quarterly analysis of 2 years shows Therapeutics' Enterprise Value stood at -$75.2 million in 2022, then spiked by 302.16% to $152.0 million in 2023.
  • Its Enterprise Value stands at $152.0 million for Q4 2023, versus -$90.2 million for Q3 2023 and -$95.6 million for Q2 2023.